MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
LaFleur Minerals Acquires McKenzie East Gold Project Expanding Val-d'Or Gold Portfolio; Advances Aggressive Drilling at Swanson Gold Project
SAGA Metals Reports Assays from R-0027 to R-0029 with Intercepts Including 53.02% Fe2O3, 6.46% TiO2, 0.441% V2O5 from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
